PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways

L Weng1, J Brown, C Eng

  • 1Clinical Cancer Genetics and Human Cancer Genetics Programs, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

Human Molecular Genetics
|February 13, 2001
PubMed

Insights

Tumor suppressor PTEN triggers cell death and G(1) arrest in breast cancer cells. PTEN-induced apoptosis is mediated by the phosphoinositol-3-kinase/Akt pathway, independent of cell cycle arrest.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • PTEN (phosphatase and tensin homolog) is a critical tumor suppressor.
  • PTEN regulates cell growth, survival, and cell cycle progression.
  • Previous studies show PTEN overexpression in MCF-7 cells induces G(1) arrest and cell death, potentially via PI3K/Akt pathways.

Purpose of the Study:

  • To investigate the mechanisms underlying PTEN-mediated growth suppression in MCF-7 breast cancer cells.
  • To elucidate the role of phosphoinositol-3-kinase (PI3K)/Akt signaling in PTEN-induced cell death and cell cycle arrest.
  • To determine if PTEN-induced apoptotic cells originate from G(1)-arrested cells.

Main Methods:

  • Overexpression of PTEN in MCF-7 breast cancer cells.
  • Culture under low growth factor conditions.
  • Treatment with caspase 9-specific inhibitor (ZVAD).
  • Overexpression of dominant-negative Akt.
  • Analysis of cell death and cell cycle distribution.

Main Results:

  • Low growth factor levels enhance PTEN-mediated growth suppression and cell death.
  • PTEN-induced cell death is blocked by ZVAD, but cell cycle arrest is unaffected.
  • PTEN-mediated cell death involves the PI3K/Akt pathway, while cell cycle arrest is PI3K/Akt-dependent and -independent.

Conclusions:

  • PTEN-induced apoptosis in MCF-7 cells does not originate from G(1)-arrested cells.
  • The PI3K/Akt pathway mediates PTEN's effect on cell death.
  • PTEN influences cell cycle arrest through both PI3K/Akt-dependent and -independent mechanisms.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...